Yeji
FDA approvaloutcome: successconf 1.00

yorvipath — FDA approval

$ASND · Ascendis Pharma A/S
Event date
August 9, 2024
666 days ago
Sponsor runway
—

Evidence

“openFDA ORIG (TYPE 1) approval of YORVIPATH — application NDA216490”
Source ↗

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

No insider Form 4 activity reported on $ASND in the 90 days around this event.
← All catalysts for $ASND